Given the recent study that GGTase I deficiency reduces lung tumor formation [11], our data suggest that GGTase I inhibitors may be used in combination with TRAIL for treatment of human lung cancer through facilitating induction of apoptosis. This evidence concerns the gene TNFSF10 and lung cancer.